Sartorius Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Sartorius şirketinin toplam hissedar öz sermayesi €3.8B ve toplam borcu €4.4B olup, bu da borç-öz sermaye oranını 115.4% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla €9.8B ve €6.0B dir. Sartorius 'in FAVÖK'ü €442.5M faiz karşılama oranı 1.8 dur. Şirketin €579.2M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

115.4%

Borç/özkaynak oranı

€4.36b

Borç

Faiz karşılama oranı	1.8x
Nakit	€579.20m
Eşitlik	€3.78b
Toplam yükümlülükler	€6.02b
Toplam varlıklar	€9.79b

Son finansal sağlık güncellemeleri

These 4 Measures Indicate That Sartorius (ETR:SRT) Is Using Debt Reasonably Well

Jul 06

Recent updates

Sartorius (ETR:SRT) Has A Pretty Healthy Balance Sheet

Jul 12

Why The 23% Return On Capital At Sartorius (ETR:SRT) Should Have Your Attention

Jun 24

If You Like EPS Growth Then Check Out Sartorius (ETR:SRT) Before It's Too Late

Jun 06

Here's Why Sartorius (ETR:SRT) Can Manage Its Debt Responsibly

Mar 28

We Think Sartorius' (ETR:SRT) Robust Earnings Are Conservative

Feb 23

Investors Interested In Sartorius Aktiengesellschaft's (ETR:SRT) Earnings

Feb 21

If You Like EPS Growth Then Check Out Sartorius (ETR:SRT) Before It's Too Late

Jan 20

Sartorius (ETR:SRT) Is Achieving High Returns On Its Capital

Nov 25

Does Sartorius (ETR:SRT) Have A Healthy Balance Sheet?

Oct 21

Do Sartorius's (ETR:SRT) Earnings Warrant Your Attention?

Aug 29

Sartorius (ETR:SRT) Hasn't Managed To Accelerate Its Returns

Aug 12

These 4 Measures Indicate That Sartorius (ETR:SRT) Is Using Debt Reasonably Well

Jul 06

Does Sartorius (ETR:SRT) Deserve A Spot On Your Watchlist?

May 12

Sartorius Aktiengesellschaft's (ETR:SRT) CEO Will Probably Have Their Compensation Approved By Shareholders

Mar 20

Is Sartorius Aktiengesellschaft's (ETR:SRT) Shareholder Ownership Skewed Towards Insiders?

Feb 22

Our Take On The Returns On Capital At Sartorius (ETR:SRT)

Feb 04

Here's Why We Think Sartorius (ETR:SRT) Is Well Worth Watching

Jan 13

Can Sartorius Aktiengesellschaft (ETR:SRT) Maintain Its Strong Returns?

Dec 24

What Type Of Shareholders Make Up Sartorius Aktiengesellschaft's (ETR:SRT) Share Registry?

Nov 18

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SRT 'nin kısa vadeli varlıkları ( €2.0B ) kısa vadeli yükümlülüklerini ( €977.0M ) aşıyor.

Uzun Vadeli Yükümlülükler: SRT 'un kısa vadeli varlıkları ( €2.0B ) uzun vadeli yükümlülüklerini ( €5.0B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SRT 'nin net borç/öz sermaye oranı ( 100% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: SRT şirketinin borç/öz sermaye oranı son 5 yılda 92.2% seviyesinden 115.4% seviyesine yükseldi.

Borç Kapsamı: SRT 'nin borcu işletme nakit akışı ( 21.2% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: SRT 'in borcuna ilişkin faiz ödemeleri EBIT ( 1.8 x kapsam) tarafından iyi karşılanmıyor.

Sartorius Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Sartorius (ETR:SRT) Has A Pretty Healthy Balance Sheet

Here's Why Sartorius (ETR:SRT) Can Manage Its Debt Responsibly

Does Sartorius (ETR:SRT) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Sartorius (ETR:SRT) Is Using Debt Reasonably Well

Recent updates

Sartorius Aktiengesellschaft to Report Fiscal Year 2024 Results on Jan 28, 2025

Labforward GmbH acquired LabTwin GmbH from Sartorius Aktiengesellschaft (XTRA:SRT3).

Sartorius Aktiengesellschaft to Report Fiscal Year 2023 Final Results on Feb 16, 2024

Sartorius Aktiengesellschaft to Report Q3, 2024 Results on Oct 17, 2024

Sartorius Aktiengesellschaft to Report Fiscal Year 2023 Results on Jan 26, 2024

Sartorius Aktiengesellschaft, Annual General Meeting, Mar 28, 2024

Sartorius Ag Lowers Earnings Forecast for the Fiscal Year 2023

Sartorius Announces Executive Board Changes

Sartorius Aktiengesellschaft Provides Revenue Guidance for the Full Year 2023

Sartorius Announces Management Changes for Sartorius North America

Sartorius Aktiengesellschaft, Annual General Meeting, Mar 29, 2023

Sartorius Aktiengesellschaft to Report First Half, 2023 Results on Jul 21, 2023

Consensus forecasts updated

First quarter 2022 earnings released

Price target decreased to €404

Sartorius Aktiengesellschaft Confirms Consolidated Financial Guidance for the Year 2022

Price target decreased to €416

Sartorius (ETR:SRT) Has A Pretty Healthy Balance Sheet

Why The 23% Return On Capital At Sartorius (ETR:SRT) Should Have Your Attention

If You Like EPS Growth Then Check Out Sartorius (ETR:SRT) Before It's Too Late

Now 21% undervalued after recent price drop

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Here's Why Sartorius (ETR:SRT) Can Manage Its Debt Responsibly

Upcoming dividend of €1.25 per share

Investor sentiment deteriorated over the past week

We Think Sartorius' (ETR:SRT) Robust Earnings Are Conservative

Investors Interested In Sartorius Aktiengesellschaft's (ETR:SRT) Earnings

Full year 2021 earnings: Revenues exceed analyst expectations

Sartorius AG Proposes Ordinary Dividend for the Year 2021

Sartorius Aktiengesellschaft Provides Consolidated Sales Revenue Guidance for the Fiscal Year 2022 and Reaffirms Consolidated Sales Revenue for the Year 2025

If You Like EPS Growth Then Check Out Sartorius (ETR:SRT) Before It's Too Late

Investor sentiment deteriorated over the past week

Sartorius Aktiengesellschaft (XTRA:SRT) entered into an agreement to acquire a 62.5% stake in ALS Automated Lab Solutions GmbH.

Sartorius (ETR:SRT) Is Achieving High Returns On Its Capital

Third quarter 2021 earnings released

Does Sartorius (ETR:SRT) Have A Healthy Balance Sheet?

Do Sartorius's (ETR:SRT) Earnings Warrant Your Attention?

Sartorius (ETR:SRT) Hasn't Managed To Accelerate Its Returns

Price target increased to €383

Second quarter 2021 earnings released

Sartorius Provides Earnings Guidance for the First Half Ended June 30, 2021

Sartorius Raises Group Earnings Guidance for the Full Year 2021

These 4 Measures Indicate That Sartorius (ETR:SRT) Is Using Debt Reasonably Well

Sartorius Plans to Acquire Remaining Shares of Cellgenix

Does Sartorius (ETR:SRT) Deserve A Spot On Your Watchlist?

First quarter 2021 earnings released: EPS €1.20

Sartorius AG Raises Revenue Guidance for the Year 2021

Upcoming Dividend of €0.70 Per Share

Sartorius Aktiengesellschaft's (ETR:SRT) CEO Will Probably Have Their Compensation Approved By Shareholders

Sartorius Revises Earnings Guidance for the Year 2021

Price target raised to €331

Is Sartorius Aktiengesellschaft's (ETR:SRT) Shareholder Ownership Skewed Towards Insiders?

Full year 2020 earnings released: EPS €3.31 (vs €2.29 in FY 2019)

Our Take On The Returns On Capital At Sartorius (ETR:SRT)

New 90-day high: €370

Sartorius Aktiengesellschaft to Report Fiscal Year 2020 Final Results on Feb 18, 2021

Here's Why We Think Sartorius (ETR:SRT) Is Well Worth Watching

Can Sartorius Aktiengesellschaft (ETR:SRT) Maintain Its Strong Returns?

Price target raised to €247

What Type Of Shareholders Make Up Sartorius Aktiengesellschaft's (ETR:SRT) Share Registry?

New 90-day high: €331

Sartorius Aktiengesellschaft to Report Q1, 2021 Results on Apr 21, 2021

New 90-day high: €303

Sartorius Aktiengesellschaft (XTRA:SRT) agreed to acquire just over 50% stake in Biological Industries Israel Beit Haemek Ltd. from Kibbutz Beit Haemek and Fortissimo Capital, L.P. managed by Fortissimo Capital for approximately €45 million.

Sartorius Aktiengesellschaft to Report Q3, 2020 Results on Oct 20, 2020

New 90-day high - €292

Sartorius Aktiengesellschaft (XTRA:SRT) and Sartorius Stedim Biotech S.A. (ENXTPA:DIM) completed the acquisition of certain businesses from Danaher Corporation (NYSE:DHR).

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin